KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Inventory (2016 - 2025)

Historic Inventory for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $28.3 million.

  • CareDx's Inventory rose 4705.91% to $28.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year increase of 4705.91%. This contributed to the annual value of $19.5 million for FY2024, which is 16.43% up from last year.
  • Latest data reveals that CareDx reported Inventory of $28.3 million as of Q3 2025, which was up 4705.91% from $27.9 million recorded in Q2 2025.
  • CareDx's Inventory's 5-year high stood at $28.3 million during Q3 2025, with a 5-year trough of $13.7 million in Q1 2021.
  • In the last 5 years, CareDx's Inventory had a median value of $18.9 million in 2022 and averaged $19.5 million.
  • As far as peak fluctuations go, CareDx's Inventory soared by 9750.97% in 2021, and later tumbled by 379.79% in 2022.
  • Over the past 5 years, CareDx's Inventory (Quarter) stood at $17.2 million in 2021, then grew by 11.91% to $19.2 million in 2022, then increased by 1.24% to $19.5 million in 2023, then rose by 0.16% to $19.5 million in 2024, then skyrocketed by 45.25% to $28.3 million in 2025.
  • Its last three reported values are $28.3 million in Q3 2025, $27.9 million for Q2 2025, and $22.9 million during Q1 2025.